Institutional members access full text with Ovid®

3D-OSEM and FP-CIT SPECT quantification: benefit for studies with a high radius of rotation?

Koch, Walter; Bartenstein, Peter; la Fougère, Christian

Nuclear Medicine Communications: October 2013 - Volume 34 - Issue 10 - p 971–977
doi: 10.1097/MNM.0b013e328364a9fd
Original Articles

Objectives: Dopamine transporter imaging with single-photon emission computed tomography (SPECT) is a valuable tool for both clinical routine and research studies. Recently, it was found that the image quality could be improved by introduction of the three-dimensional ordered subset expectation maximization (3D-OSEM) reconstruction algorithm, which provides resolution recovery. The aim of this study was to systematically evaluate the potential benefits of 3D-OSEM in comparison with 2D-OSEM under critical imaging conditions, for example, scans with a high radius of rotation.

Materials and methods: Monte Carlo simulation scans of a digital brain phantom with various disease states and different radii of rotation ranging from 13 to 30 cm were reconstructed with both 2D-OSEM and 3D-OSEM algorithms. Specific striatal binding and putamen-to-caudate ratios were determined and compared with true values in the phantom.

Results: The percentage recovery of true striatal binding was similar between both reconstruction algorithms at the minimum rotational radius; however, at the maximum rotational radius, it decreased from 53 to 43% for 3D-OSEM and from 52 to 26% for 2D-OSEM. 3D-OSEM matched the true putamen-to-caudate ratios more closely than did 2D-OSEM in scans with high SPECT rotation radii.

Conclusion: 3D-OSEM offers a promising image quality gain. It outperforms 2D-OSEM, particularly in studies with limited resolutions (such as scans acquired with a high radius of rotation) but does not improve the accuracy of the putamen-to-caudate ratios. Whether the benefits of better recovery in studies with higher radii of rotation could potentially increase the diagnostic power of dopamine transporter SPECT in patients with borderline striatal radiotracer binding, however, needs to be further examined.

Department of Nuclear Medicine, University of Munich, Munich, Germany

Correspondence to Walter Koch, MD, Department of Nuclear Medicine, University of Munich, Marchioninistr 15, 81377 Munich, Germany Tel: +49 89 7095 4646; fax: +49 89 7095 7646; e-mail:

Received March 17, 2013

Accepted June 28, 2013

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins